Business
Novocure Opens Office in Montreal to Expand and Support Growing Business in Canada
Novocure chose Montreal because of its innovative culture, world-class universities and hospitals, access to top talent and quality of life ROOT,
About this update from Novocure Limited
[{"type":"text","content":"\nNovocure chose Montreal because of its innovative culture, world-class universities and hospitals, access to top talent and quality of life\n\n ROOT, Switzerland--(BUSINESS WIRE)--\nNovocure (NASDAQ: NVCR) today announced it has opened a new office in Montreal to expand and support its growing business in Canada. Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields (TTFields). TTFields are electric fields that exert physical forces to kill cancer cells via a variety of mechanisms.\nThis press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221115005460/en/From left, Dr. David Roberge, Professor of Radiology, Radiation Oncology & Nuclear at the CHUM Research Centre and Future President of the Canadian Association of Radiation Oncology; Romina Ferro, Marketing & Communications Manager Brain Tumour Foundation of Canada; Shannon LaHay, Chief Executive Officer, Brain Tumour Foundation of Canada; Thomas Hefti, Novocure Senior Vice President, EMEA; Jovan Antunovic, Novocure Country Manager, Canada; Christine Mormont, Novocure Director, Medical Affairs, Canada; and Pritesh Shah, Novocure Chief Commercial Officer, celebrate the inauguration of Novocure’s Montreal office on Nov. 2. (Photo: Business Wire)\nNovocure chose Montreal because of its innovative culture, world-class universities and hospitals, access to top talent and quality of life, including investments the city is making in its public transportation system.\n\n“We’re very proud to say that Montreal is now home for Novocure Canada,” said Jovan Antunovic, Country Manager of Novocure Canada. “We have a great opportunity to grow our business and bring our therapy to more patients who can benefit throughout Canada.”\n\nNovocure inaugurated its Montreal office on Nov. 2, welcoming Novocure leadership and colleagues; Dr. David Roberge, Professor of Radiology, Radiation Oncology & Nuclear at the CHUM Research Centre and Future President of the Canadian Association of Radiation Oncology; Shannon LaHay, Chief Executive Officer, Brain Tumour Foundation of Canada; and Romina Ferro, Marketing & Communications Manager Brain Tumour Foundation of Canada, among other guests to celebrate thi...